Swiss Study on Spider Bites

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

About spider bites in Middle Europe, there are published only a dozen cases. The investigators suspect that they may be much more frequent than reflected by the literature analysis (but much less dangerous than thought by people). From June 1st 2011 to November 30st 2012 the investigators collect clinical data on patients treated for spider bites in Switzerland.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion criteria: Every human treated for suspected spider bite in Switzerland willing to participate this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spider Bite

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

humans insect bites

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spider bite patients

All patients treated for an actual spider bite by a Swiss physician during study period.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult or child treated for a suspected spider bite in Switzerland

Exclusion Criteria

* unwillingness to participate to the study

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Markus P. Gnädinger, MD

Role: PRINCIPAL_INVESTIGATOR

Department of General Practice University Hospital Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Praxis Dr. med. Markus Gnaedinger

Steinach, Canton of St. Gallen, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Gnadinger M, Nentwig W, Fuchs J, Ceschi A. Swiss prospective study on spider bites. Swiss Med Wkly. 2013 Sep 4;143:w13877. doi: 10.4414/smw.2013.13877. eCollection 2013.

Reference Type DERIVED

PMID: 24019004 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SSSB

Identifier Type: -

Identifier Source: org_study_id